When creating drug delivery devices that are designed as a platform for use with multiple drugs, the approach to human factors studies becomes even more important. Since the specific user group is not yet defined any study must be designed to accommodate the needs of a broad range of both users and therapy areas. Finola Austin at Owen Mumford Pharmaceutical Services outlines a user evaluation strategy for platform devices and explains that we carried out a successful human factors study under pandemic restrictions.